0001104659-23-110157.txt : 20231019 0001104659-23-110157.hdr.sgml : 20231019 20231019165530 ACCESSION NUMBER: 0001104659-23-110157 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231018 FILED AS OF DATE: 20231019 DATE AS OF CHANGE: 20231019 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PATEL DINESH V PH D CENTRAL INDEX KEY: 0001120477 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37852 FILM NUMBER: 231335307 MAIL ADDRESS: STREET 1: C/O PROTAGONIST THERAPEUTICS, INC. STREET 2: 521 COTTONWOOD DRIVE, SUITE 100 CITY: MILPITAS STATE: CA ZIP: 95035 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Protagonist Therapeutics, Inc CENTRAL INDEX KEY: 0001377121 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 980505495 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 7707 GATEWAY BLVD., SUITE 140 CITY: NEWARK STATE: CA ZIP: 94560-1160 BUSINESS PHONE: (510) 474-0170 MAIL ADDRESS: STREET 1: 7707 GATEWAY BLVD., SUITE 140 CITY: NEWARK STATE: CA ZIP: 94560-1160 FORMER COMPANY: FORMER CONFORMED NAME: Protagonist Therapeutics Inc DATE OF NAME CHANGE: 20130605 FORMER COMPANY: FORMER CONFORMED NAME: Protagonist Inc DATE OF NAME CHANGE: 20061002 4 1 tm2328807-1_4seq1.xml OWNERSHIP DOCUMENT X0508 4 2023-10-18 0 0001377121 Protagonist Therapeutics, Inc PTGX 0001120477 PATEL DINESH V PH D C/O PROTAGONIST THERAPEUTICS, INC. 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160 1 1 0 0 President and CEO 0 Common Stock 2023-10-18 4 M 0 6000 4.21 A 609347 D Stock Option (right to buy) 4.21 2023-10-18 4 M 0 6000 0.00 D 2026-04-29 Common Stock 6000 54000 D Includes an aggregate of 401 shares acquired by the Reporting Person under the Issuer's 2016 Employee Stock Purchase Plan on September 9, 2023. These stock options are fully vested. /s/ Matthew Gosling, Attorney-in-Fact for Dinesh V. Patel, Ph.D. 2023-10-19